Masoud Dara, Andrei Dadu, Kristin Kremer, Richard Zaleskis, Hans H. P. Kluge


June 2013, Volume 22, Issue 4, pp 549 - 555 Review Article Read Full Article 10.1007/s00586-012-2339-3

First Online: 08 May 2012

Purpose

To provide an overview of the tuberculosis (TB) and multi-drug resistant tuberculosis (MDR-TB) in the WHO European Region and evolution of public health response with focus on extra-pulmonary tuberculosis and Pott’s disease.

Methods

Authors reviewed regional strategic documents related to TB. The epidemiologic data were reviewed and analyzed.

Results

In the absence of associated pulmonary TB, Pott’s disease is reported as extra-pulmonary TB (up to 47 % of all TB cases in some settings). Due to limitations of the surveillance system, the epidemiology of Pott’s disease and its treatment success are unknown. The Stop TB Strategy and Consolidated Action Plan to Prevent and Combat M/XDR-TB provide comprehensive roadmaps to address all types of TB.

Conclusions

There is a need to further analyze country data to document the extent of Pott’s disease and develop specific guidelines for timely diagnosis and treatment of Pott’s disease.


Read Full Article